Synthesis and in vitro biological evaluation of new pyrimidines as glucagon-like peptide-1 receptor agonists
- Shaikha S. AlNeyadi,
- Abdu Adem(corresponding author),
- Naheed Amer,
- Alaa A. Salem,
- Ibrahim M. Abdou
- United Arab Emirates University
Abstract
The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small-molecule GLP-1 receptor agonists. In this study, two series of new pyrimidine derivatives were designed and synthesized using an efficient route, and were evaluated in terms of GLP-1 receptor agonist activity. In the first series, novel pyrimidines substituted at positions 2 and 4 with groups varying in size and electronic properties were synthesized in a good yield (78–90%). In the second series, the designed pyrimidine templates included both urea and Schiff base linkers, and these compounds were successfully produced with yields of 77–84%. In vitro experiments with cultured cells showed that compounds 3a and 10a (10−15–10−9 M) significantly increased insulin secretion compared to that of the control cells in both the absence and presence of 2.8 mM glucose; compound 8b only demonstrated significance in the absence of glucose. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1 receptor agonists that can be administered orally.
Research Output Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 5071-5075 (5 pages)Journal (Volume, Issue Number)
Bioorganic and Medicinal Chemistry Letters (Volume 27, Issue 22)Publication milestones
- Published - 15/11/2017
Publication status
ISSN
0960-894XPublication IDs
- Scopus: 85030569246
- PubMed: 28988756
Documents and links
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
